Lynch Syndrome & Hereditary Colon Cancer Risk Assessment Panel

Unique Identifier:

ML-N002


Name on Requisition:

Lynch Syndrome & Hereditary Colon Cancer Risk Assessment Panel


Product Line:

NH


Panel Group:

Hereditary Cancer Panels


Panel Name:

Lynch Syndrome & Hereditary Colon Cancer Risk Assessment Panel


Methodology

Molecular
NGS


Test Description and clinical significance

Genes
APC, ATM, AXIN2, BRCA1, BRCA2, BARD1, BMPR1A, BRIP1, CDH1, CHEK2, EPCAM, MLH1, MRE11A, MSH2, MSH3, MSH6, MUTYH, NF1, NTHL1, PALB2, PMS2, POLD1, POLE, PTEN, RAD50, RAD51C, RAD51D, SMAD4, STK11, TP53

Disease:
Lynch Syndrome & Colon Cancer

The Lynch Syndrome & Hereditary Colon Cancer Risk Assessment Panel analyzes germline variants in DNA mismatch repair (MMR) genes—MLH1, MSH2, MSH6, PMS2, and EPCAM—and other colorectal cancer–associated genes. Pathogenic variants confer increased risk for colorectal, endometrial, gastric, and other Lynch-associated cancers. Results provide diagnostic confirmation, enable family risk assessment, and inform preventive and surveillance strategies.


Specimen Requirements

Preparation:
PB, saliva

Collection:
Specimen should contain least 0.5 mL of peripheral blood (lower volumes may be accepted if situation demands), but we prefer larger specimens in case of a low content of nucleated cells. For saliva, it is recommended to request 1.5-2.0 ml of saliva to be collected from each patient.

Stability:
4 to 7 days refrigerated fpr PB and upto 1 year for slaiva at room temperature

Unacceptable Conditions:
Specimen submitted is in the incorrect fixative or anticoagulant. Specimen received after the stability date. Gross hemolysis. Frozen specimen. Insufficient specimen. Unlabeled. Left un-refrigerated for an extended period.


Storage & Transport

4 to 7 days refrigerated fpr PB and upto 1 year for slaiva at room temperature


CPT(s)

81435


New York Approved

Yes


TAT

14-21


Requisition Type

NH


Levels of Service

Full


DexS Code

Z03NY


Prefix

MI


*The CPT codes provided are for informational purposes only and are based on AMA guidelines The billing party is solely responsible for correct CPT coding.

Discover more.

A Model Experience

With core values rooted in service and integrity, our leadership team sets the bar high.

We consistently strive to set the model for exactly how a reference laboratory should engage with both physicians and patients.

Accredited and Certified

siParadigm is accredited by CLIA (Clinical Laboratory Improvement Amendments) and certified by CAP (College of American Pathologists).

We also hold select state licensure where required.